Invitrogen™ Human CD264 (TRAIL-R4) Synthetic Peptide
DcR2 Synthetic Peptide, PEP-0022, from Invitrogen.
- Gene ID (Enter)
- 8793
- Species
- Human
- Purification method
- Purified
- Accession number
- Q9UBN6
- Common name
- Human CD264 (TRAIL-R4)
- Brand
- Invitrogen
DcR2 Synthetic Peptide, PEP-0022, from Invitrogen.
DcR2 Synthetic Peptide, PEP-0022, from Invitrogen.
TRAIL (also known as Apo-2L) is a member of the tumor necrosis factor (TNF) ligand family that rapidly induces apoptosis in a variety of transformed cell lines. A fourth member of the emerging TRAIL receptor family, TRAIL-R4, has signaling capacity similar to that of TRAIL-R1 and TRAIL-R2 with respect to NF-kappaB activation, but differs in its inability to induce apoptosis. Like TRAIL-R1 and TRAIL-R2, this receptor shows widespread tissue expression. The human TRAIL-R4 gene has been mapped to chromosome 8p22-21, clustered with three other TRAIL receptors.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15246249 |
| Specifications | |
| Gene ID (Enter) | 8793 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q9UBN6 |
| Common name | Human CD264 (TRAIL-R4) |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | TNFRSF10D |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-0022 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 96 00 |